My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2024/2102 of 30 July 2024 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use of the novel food 2'-Fucosyllactose and as regards the specifications of the novel food 2'-Fucosyllactose produced with a derivative strain of Escherichia coli BL-21

Commission Implementing Regulation (EU) 2024/2102 of 30 July 2024 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use of the novel food 2'-Fucosyllactose and as regards the specifications of the novel food 2'-Fucosyllactose produced with a derivative strain of Escherichia coli BL-21

Implementing Regulation (EU) 2024/2102 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The Annex to Implementing Regulation (EU) 2017/2470 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX The Annex to Implementing Regulation (EU) 2017/2470 is amended as follows: (1) in Table 1 (Authorised novel foods), the entry for 2'-Fucosyllactose is replaced by the following: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements ‘ 2 ′ -Fucosyllactose Specified food category Maximum levels 1. The designation of the novel food on the labelling of the foodstuffs containing it shall be “2′-Fucosyllactose”. 2. The labelling of food supplements containing 2′-Fucosyllactose shall bear a statement that the supplements should not be used if other foods with added 2′-fucosyllactose are consumed the same day. 3. The labelling of food supplements containing 2′-Fucosyllactose intended for young children shall bear a statement that the supplements should not be used if breast milk or other foods with added 2′-fucosyllactose are consumed the same day.’   Unflavoured pasteurised and sterilised (including UHT) milk-based products 1,2 g/l Unflavoured fermented milk-based products 1,2 g/l for beverages 19,2 g/kg for products other than beverages Flavoured fermented milk-based products including heat-treated products 1,2 g/l for beverages 19,2 g/kg for products other than beverages Dairy analogues, including beverage whiteners 1,2 g/l for beverages 12 g/kg for products other than beverages 400 g/kg for whitener Cereal bars 12 g/kg Table-top sweeteners 200 g/kg Infant formula as defined in Regulation (EU) No 609/2013 3,0 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer Follow-on formula as defined in Regulation (EU) No 609/2013 3,64 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer Processed cereal-based foods and baby foods for infants and young children as defined in Regulation (EU) No 609/2013 12 g/kg for products other than beverages 1,2 g/l for liquid food ready for use, marketed as such or reconstituted as instructed by the manufacturer Milk based drinks and similar products intended for young children 1,2 g/l for milk-based drinks and similar products in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer Foods for special medical purposes as defined in Regulation (EU) No 609/2013 In accordance with the particular nutritional requirements of the persons for whom the products are intended Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 4,8 g/l for drinks 40 g/kg for bars Bread and pasta products bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Implementing Regulation (EU) No 828/2014 60 g/kg Flavoured drinks 1,2 g/l Coffee, tea (excluding black tea), herbal and fruit infusions, chicory; tea, herbal and fruit infusions and chicory extracts; tea, plant, fruit and cereal preparations for infusions, as well as mixes and instant mixes of these products 9,6 g/l – the maximum level refers to the products ready to use Food supplements as defined in Directive 2002/46/EC, for the general population, excluding infants 3,0 g/day for general population 1,2 g/day for young children (2) in Table 2 (Specifications) the entry for 2′-Fucosyllactose (microbial source) is replaced by the following: Specifications   Data protection   Definition: Chemical name: α-L-Fucopyranosyl-(1→2)-β-D-galactopyranosyl-(1→4)-D-glucopyranose Chemical formula: C 18 H 32 O 15 CAS No: 41263-94-9 Molecular weight: 488,44 g/mol 2′-Fucosyllactose produced with a genetically modified strain of Corynebacterium glutamicum ATCC 13032 authorised on 16 May 2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: “Advanced Protein Technologies Corporation”, 7th Floor GyeongGi-BioCenter, 147, Gwanggyo-ro, Yeongtong-gu, Suwon-si Gyeonggi-do, 16229 South Korea. During the period of data protection, 2′-Fucosyllactose produced with a genetically modified strain of Corynebacterium glutamicum ATCC 13032 is authorised for placing on the market within the Union only by “Advanced Protein Technologies Corporation” unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of “Advanced Protein Technologies Corporation”. End date of the data protection: 16 May 2028.’ ‘ 2 ′ -Fucosyllactose (microbial source) Source: Genetically modified strain of Escherichia coli K-12 Source: Genetically modified strain of Escherichia coli BL-21 Source : Genetically modified strain of Corynebacterium glutamicum ATCC 13032 Description: 2′-Fucosyllactose is a white to off-white powder that is produced by a microbiological process. Purity: 2′-Fucosyllactose: ≥ 83 % D-Lactose: ≤ 10,0 % L-Fucose: ≤ 2,0 % Difucosyl-D-lactose: ≤ 5,0 % 2′-Fucosyl-D-lactulose: ≤ 1,5 % Sum of saccharides (2′-Fucosyllactose, D-Lactose, L-Fucose, Difucosyl-D-lactose, 2′-Fucosyl-D-lactulose): ≥ 90 % pH (20 C, 5 % solution): 3,0-7,5 Water: ≤ 9,0 % Sulphated ash: ≤ 2,0 % Acetic acid: ≤ 1,0 % Residual proteins: ≤ 0,01 % Microbiological criteria: Aerobic mesophilic bacteria total count: ≤ 3 000 CFU/g Yeasts: ≤ 100 CFU/g Moulds: ≤ 100 CFU/g Endotoxins: ≤ 10 EU/mg CFU: Colony Forming Units; EU: Endotoxin Units Description: 2′-Fucosyllactose is a white to off white powder and the liquid concentrate (45 % ± 5 % w/v) aqueous solution is a colourless to slight yellow clear aqueous solution. 2′-Fucosyllactose is produced by a microbiological process. Purity: 2′-Fucosyllactose: ≥ 90 % Lactose: ≤ 5,0 % Fucose: ≤ 3,0 % 3-Fucosyllactose: ≤ 5,0 % Fucosylgalactose: ≤ 3,0 % Difucosyllactose: ≤ 5,0 % Glucose: ≤ 3,0 % Galactose: ≤ 3,0 % Water: ≤ 9,0 % (powder) Ash, sulphated: ≤ 0,5 % (powder and liquid) Residual proteins: ≤ 0,01 % (powder and liquid) Heavy Metals: Lead: ≤ 0,02 mg/kg (powder and liquid) Arsenic: ≤ 0,2 mg/kg (powder and liquid) Cadmium: ≤ 0,1 mg/kg (powder and liquid) Mercury: ≤ 0,5 mg/kg (powder and liquid) Microbiological criteria: Total plate count: ≤ 10 4 CFU/g (powder), ≤ 5 000 CFU/g (liquid) Yeasts and Moulds: ≤ 100 CFU/g (powder); ≤ 50 CFU/g (liquid) Enterobacteriaceae/Coliforms: absence in 11 g (powder and liquid) Salmonella: negative/100 g (powder), negative/200 ml (liquid) Cronobacter: negative/100 g (powder), negative/200 ml (liquid) Endotoxins: ≤ 10 EU/mg (powder), ≤ 10 EU/μl (liquid) Aflatoxin M1: ≤ 0,025 μg/kg (powder and liquid) CFU: Colony Forming Units; EU: Endotoxin Units Description: 2′-Fucosyllactose is a white to off white/ivory powder that is produced by a microbiological process. Purity: 2′-Fucosyllactose (w/w dry matter): ≥ 94,0 % D-Lactose (w/w dry matter): ≤ 3,0 % L-Fucose (w/w dry matter): ≤ 3,0 % 3-Fucosyllactose (w/w dry matter): ≤ 3,0 % Difucosyllactose (w/w dry matter): ≤ 2,0 % D-Glucose (w/w dry matter): ≤ 3,0 % D-Galactose (w/w dry matter): ≤ 3,0 % Water: ≤ 9,0 % Ash: ≤ 0,5 % Residual proteins: ≤ 0,005 % Contaminants : Arsenic: ≤ 0,03 mg/kg Aflatoxin M1: ≤ 0,025 μg/kg Ethanol: ≤ 1 000 mg/kg Microbiological criteria : Total plate count: ≤ 500 CFU/g Yeasts and Moulds: ≤ 100 CFU/g Enterobacteriaceae: absence in 10 g Salmonella : absence in 25 g Cronobacter spp.: absence in 10 g Endotoxins: ≤ 100 EU/g CFU: Colony Forming Units; EU: Endotoxin Units

Other acts of the same type
Commission Implementing Regulation (EU) 2017/210 of 7 February 2017 concerning the authorisation of a preparation of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced by Talaromyces versatilis sp. nov. IMI CC 378536 and Talaromyces versatilis sp. nov. DSM 26702 as a feed additive for laying hens (holder of the authorisation Adisseo France S.A.S.) (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/211 of 7 February 2017 concerning the authorisation of a preparation of endo-1,4-beta-xylanase (EC 3.2.1.8) produced by Bacillus subtilis (LMG-S 15136) as a feed additive for poultry, weaned piglets and pigs for fattening, and amending Regulations (EC) No 1259/2004, (EC) No 1206/2005, and (EC) No 322/2009 and repealing Regulation (EC) No 516/2007 (holder of authorisation Beldem, a division of Puratos NV) (Text with EEA relevance. )Commission Regulation (EU) 2017/212 of 7 February 2017 designating the EU reference laboratory for peste des petits ruminants, laying down additional responsibilities and tasks for this laboratory and amending Annex VII to Regulation (EC) No 882/2004 of the European Parliament and of the Council (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/226 of 7 February 2017 concerning the classification of certain goods in the Combined NomenclatureCommission Delegated Regulation (EU) 2017/867 of 7 February 2017 on classes of arrangements to be protected in a partial property transfer under Article 76 of Directive 2014/59/EU of the European Parliament and of the Council (Text with EEA relevance. )Council Implementing Regulation (EU) 2017/199 of 6 February 2017 implementing Article 9(5) of Regulation (EC) No 1183/2005 imposing certain specific restrictive measures directed against persons acting in violation of the arms embargo with regard to the Democratic Republic of the CongoCommission Implementing Regulation (EU) 2017/201 of 6 February 2017 amending Regulation (EU) No 37/2010 to classify the substance fluralaner as regards its maximum residue limit (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/218 of 6 February 2017 on the Union fishing fleet registerCommission Implementing Regulation (EU) 2017/194 of 3 February 2017 concerning the authorisation of the preparation of Lactobacillus diolivorans DSM 32074 as a feed additive for all animal species (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/195 of 3 February 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of several active substances listed in Part B of the Annex to Implementing Regulation (EU) No 686/2012 (AIR IV renewal programme) (Text with EEA relevance. )Commission Delegated Regulation (EU) 2017/698 of 3 February 2017 amending Delegated Regulation (EU) No 1062/2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council concerning the making available on the market and use of biocidal products (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/187 of 2 February 2017 concerning the authorisation of a preparation of Bacillus subtilis (DSM 28343) as a feed additive for chickens for fattening (holder of authorisation Lactosan GmbH & Co. KG) (Text with EEA relevance. )

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next